IGF-1 LR3

IGF-1 LR3 – Research Grade Peptide

IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a synthetic peptide analogue supplied exclusively for laboratory research and analytical purposes. It is a modified version of IGF-1 designed for use in controlled research settings to study cellular and biochemical processes.

IGF-1 LR3 is classified as an unlicensed investigational compound and has not been authorised for use as a medicinal product in the United Kingdom by the Medicines and Healthcare products Regulatory Agency (MHRA) or any other regulatory authority.

Research Context

IGF-1 LR3 is commonly investigated in relation to:

• Insulin-like growth factor receptor interactions

• Cellular signalling pathways

• Protein and peptide research models

These areas remain under ongoing scientific investigation. Any references are provided for informational purposes only and do not represent established clinical outcomes.

Intended Use

• For in vitro research use only

• Not for human or veterinary use

• Not intended for medicinal, diagnostic, or therapeutic purposes

This product must only be handled by qualified professionals within appropriate laboratory environments.

Regulatory Compliance

This product is not a licensed medicine and must not be marketed, sold, or used as such. It is supplied strictly on the condition that it will be used for legitimate research purposes only.

Disclaimer

All information provided is for educational and scientific purposes only. No claims are made regarding safety, efficacy, or suitability for any medical application. The supplier does not promote or condone use outside of controlled research settings.